Works matching DE "TELAPREVIR"
Results: 203
Chronic Hepatitis C Treatment in Patients with Drug Injection History: Findings of the INTEGRATE Prospective, Observational Study.
- Published in:
- 2017
- By:
- Publication type:
- Report
Efficacy and safety of telaprevir and boceprevir in patients with hepatitis C genotype 1: a meta-analysis.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2014, v. 39, n. 1, p. 14, doi. 10.1111/jcpt.12106
- By:
- Publication type:
- Article
Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 1, p. 93, doi. 10.1111/apt.12546
- By:
- Publication type:
- Article
Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 1, p. 85, doi. 10.1111/apt.12544
- By:
- Publication type:
- Article
Commentary: triple therapy for patients with chronic hepatitis C and advanced fibrosis?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 11/12, p. 1407, doi. 10.1111/apt.12526
- By:
- Publication type:
- Article
Telaprevir-based triple therapy for chronic hepatitis C patients with advanced fibrosis: a prospective clinical study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 9, p. 1076, doi. 10.1111/apt.12494
- By:
- Publication type:
- Article
Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 2, p. 118, doi. 10.1111/apt.12350
- By:
- Publication type:
- Article
Health-related quality of life in genotype 1 treatment-naïve chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 2, p. 124, doi. 10.1111/apt.12354
- By:
- Publication type:
- Article
Efficacy and safety profile of boceprevir- or telaprevir-based triple therapy or dual peginterferon alfa-2a or alfa-2b plus ribavirin therapy in chronic hepatitis C: the real-world PegBase observational study.
- Published in:
- Annals of Gastroenterology, 2017, v. 30, n. 3, p. 327, doi. 10.20524/aog.2017.0136
- By:
- Publication type:
- Article
Interferon-based combination treatment for chronic hepatitis C in the era of direct acting antivirals.
- Published in:
- Annals of Gastroenterology, 2015, v. 28, n. 1, p. 55
- By:
- Publication type:
- Article
Interpreting discordant indirect and multipletreatment comparison meta-analyses:an evaluation of direct acting antiviralsfor chronic hepatitis C infection.
- Published in:
- Clinical Epidemiology, 2013, v. 5, p. 173, doi. 10.2147/CLEP.S44273
- By:
- Publication type:
- Article
Synergistic anti-hepatitis C virus activity of Ruta angustifolia extract with NS3 protein inhibitor.
- Published in:
- Journal of Basic & Clinical Physiology & Pharmacology, 2019, v. 30, n. 6, p. N.PAG, doi. 10.1515/jbcpp-2019-0348
- By:
- Publication type:
- Article
Therapeutic Potential of and Treatment with Boceprevir/Telaprevir-Based Triple-Therapy in HIV/Chronic Hepatitis C Co-Infected Patients in a Real-World Setting.
- Published in:
- AIDS Patient Care & STDs, 2014, v. 28, n. 5, p. 221, doi. 10.1089/apc.2013.0359
- By:
- Publication type:
- Article
Effects of boceprevir and telaprevir on the pharmacokinetics of dolutegravir.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 78, n. 5, p. 1043, doi. 10.1111/bcp.12428
- By:
- Publication type:
- Article
Current and emerging antiviral treatments for hepatitis C infection.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 75, n. 4, p. 931, doi. 10.1111/j.1365-2125.2012.04419.x
- By:
- Publication type:
- Article
The effect of CYP3A inhibitors and inducers on the pharmacokinetics of telaprevir in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 75, n. 2, p. 431, doi. 10.1111/j.1365-2125.2012.04345.x
- By:
- Publication type:
- Article
High Frequency of Severe Telaprevir-associated Skin Eruptions in Clinical Practice.
- Published in:
- Acta Dermato-Venereologica, 2016, v. 96, n. 1, p. 97, doi. 10.2340/00015555-2174
- By:
- Publication type:
- Article
A case of sustained virologic response of HCV with telaprevir-based therapy in a patient with HIV and end stage kidney disease.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Asymmetric Synthesis of 3,4-Disubstituted Proline Derivatives: Application in Synthesis of Hepatitis C Virus Protease Inhibitor Telaprevir.
- Published in:
- European Journal of Organic Chemistry, 2014, v. 2014, n. 36, p. 8101, doi. 10.1002/ejoc.201403069
- By:
- Publication type:
- Article
Analysis of Naturally Occurring Resistance-Associated Variants to NS3/4A Protein Inhibitors, NS5A Protein Inhibitors, and NS5B Polymerase Inhibitors in Patients With Chronic Hepatitis C.
- Published in:
- Gene Expression (1052-2166), 2018, v. 18, n. 1, p. 63, doi. 10.3727/105221617X15100607143377
- By:
- Publication type:
- Article
Can curative antivirals benefit porphyria cutanea tarda in hepatitis C patients?
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2017, v. 31, n. 4, p. e194, doi. 10.1111/jdv.13936
- By:
- Publication type:
- Article
Incivo on the PBS.
- Published in:
- 2013
- Publication type:
- Product Review
Hep-C drugs listed on PBS.
- Published in:
- Australian Journal of Pharmacy, 2013, v. 94, n. 1115, p. 40
- Publication type:
- Article
Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis.
- Published in:
- QJM: An International Journal of Medicine, 2013, v. 106, n. 2, p. 153, doi. 10.1093/qjmed/hcs214
- By:
- Publication type:
- Article
Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemia.
- Published in:
- Liver International, 2015, v. 35, n. 11, p. 2358, doi. 10.1111/liv.12931
- By:
- Publication type:
- Article
Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/ HCV genotype 1-coinfected patients.
- Published in:
- Liver International, 2015, v. 35, n. 9, p. 2090, doi. 10.1111/liv.12799
- By:
- Publication type:
- Article
Drug-drug interactions of telaprevir and boceprevir in HCV-monoinfected and HIV/ HCV-coinfected patients can modify the adherence.
- Published in:
- Liver International, 2015, v. 35, n. 5, p. 1557, doi. 10.1111/liv.12729
- By:
- Publication type:
- Article
Proving risk factors with laboratory data may be more valuable.
- Published in:
- Liver International, 2015, v. 35, n. 2, p. 680, doi. 10.1111/liv.12677
- By:
- Publication type:
- Article
Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study.
- Published in:
- Liver International, 2015, v. 35, n. 2, p. 448, doi. 10.1111/liv.12703
- By:
- Publication type:
- Article
Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantation.
- Published in:
- Liver International, 2015, v. 35, n. 1, p. 176, doi. 10.1111/liv.12532
- By:
- Publication type:
- Article
Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy.
- Published in:
- Liver International, 2014, v. 34, n. 7, p. 1018, doi. 10.1111/liv.12342
- By:
- Publication type:
- Article
How to optimize HCV therapy in genotype 1 patients: predictors of response.
- Published in:
- Liver International, 2013, v. 33, p. 23, doi. 10.1111/liv.12053
- By:
- Publication type:
- Article
Optimal treatment with telaprevir for chronic HCV infection.
- Published in:
- Liver International, 2013, v. 33, p. 3, doi. 10.1111/liv.12079
- By:
- Publication type:
- Article
Patients with HCV and F1 and F2 fibrosis stage: treat now or wait?
- Published in:
- Liver International, 2013, v. 33, p. 105, doi. 10.1111/liv.12066
- By:
- Publication type:
- Article
Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver.
- Published in:
- Liver International, 2012, v. 32, n. 10, p. 1477, doi. 10.1111/j.1478-3231.2012.02856.x
- By:
- Publication type:
- Article
Effect of hepatitis B and C clearance on atazanavir exposure.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Immobilised whole-cell recombinant monoamine oxidase biocatalysis.
- Published in:
- Applied Microbiology & Biotechnology, 2015, v. 99, n. 3, p. 1229, doi. 10.1007/s00253-014-5983-1
- By:
- Publication type:
- Article
Cutaneous side-effects of antihepatitis C treatment: the U.K. experience.
- Published in:
- British Journal of Dermatology, 2015, v. 172, n. 1, p. 292, doi. 10.1111/bjd.13227
- By:
- Publication type:
- Article
Successful Antiviral Triple Therapy in a Longstanding Refractory Hepatitis C Virus Infection with an Acute Kidney Injury.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Telaprevir Warning.
- Published in:
- JAMA: Journal of the American Medical Association, 2013, v. 309, n. 4, p. 333, doi. 10.1001/jama.2013.22
- Publication type:
- Article
Hepatitis C new drugs.
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. O29, doi. 10.1186/1758-2652-13-S4-O29
- By:
- Publication type:
- Article
Headache Associated With Telaprevir Treatment.
- Published in:
- Headache: The Journal of Head & Face Pain, 2014, v. 54, n. 1, p. 168, doi. 10.1111/head.12238
- By:
- Publication type:
- Article
Telaprevir for HIV/Hepatitis C Virus–Coinfected Patients Failing Treatment With Pegylated Interferon/Ribavirin (ANRS HC26 TelapreVIH): An Open-Label, Single-Arm, Phase 2 Trial.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 12, p. 1768
- By:
- Publication type:
- Article
Editorial Commentary: Does HIV Remain a Risk Factor for Achieving Sustained Virologic Response Under Direct Acting Antiviral–Based Modern Hepatitis C Virus Therapy?
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Telaprevir in the Treatment of Acute Hepatitis C Virus Infection in HIV-Infected Men.
- Published in:
- Clinical Infectious Diseases, 2014, v. 58, n. 6, p. 873
- By:
- Publication type:
- Article
Role of Ritonavir in the Drug Interactions Between Telaprevir and Ritonavir-Boosted Atazanavir.
- Published in:
- Clinical Infectious Diseases, 2014, v. 58, n. 2, p. 268, doi. 10.1093/cid/cit693
- By:
- Publication type:
- Article
Drug-Drug Interactions in the Treatment of HCV Among People Who Inject Drugs.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. Supp 2, p. S125, doi. 10.1093/cid/cit299
- By:
- Publication type:
- Article
Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. 2, p. 221, doi. 10.1093/cid/cit226
- By:
- Publication type:
- Article
Closing in on the Target: Sustained Virologic Response in Hepatitis C Virus Genotype 1 Infection Response-Guided Therapy.
- Published in:
- Clinical Infectious Diseases, 2013, v. 56, n. 10, p. 1466, doi. 10.1093/cid/cit025
- By:
- Publication type:
- Article
Carlson A et al (Clin Infect Dis 2013; 56:552–4).
- Published in:
- 2013
- Publication type:
- Correction Notice